Evaluating dapagliflozin for patients with type 2 diabetes and hypertension

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to assess the efficacy and safety of dapagliflozin in patients diagnosed with type 2 diabetes mellitus who also have hypertension. Participants will be monitored for their response to the medication, specifically focusing on its impact on blood sugar levels and blood pressure. The study will include individuals who are scheduled to receive specific formulations of dapagliflozin and will require their cooperation throughout the trial duration.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Those diagnosed with type 2 diabetes mellitus accompanied by hypertension who are scheduled to be administrated Trudapa Tab. or Trudapa M SR Tab.
* Those who voluntarily signed a written personal information agreement to participate in this clinical study.
* Those able to understand this study, be cooperative in the execution of the study, and participate in the study until its completion.

Exclusion Criteria:

* Patients with secondary hypertension: Secondary hypertension is not limited to the following diseases; (e.g., coarctation of the aorta, hyperaldosteronism, renal artery stenosis, pheochromocytoma, Cushing's syndrome and polycystic kidney disease, etc.)
* Those who have a history of taking dapagliflozin within 4 weeks of baseline (Visit 1)
* Those who are expected to need insulin prescription during the study period
* Pregnant women, breast-feeding women

Where it's running

• Gachon University Gil Medical Center
  Incheon, Namdong-gu, South Korea Recruiting

Study contacts

• Study coordinator: Shinyoung Oh
• Email: syoh@boryung.co.kr
• Phone: +82-2-708-8000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Linking social care with healthcare to help manage chronic diseases

  This trial tests whether pairing patients with trained community health workers can help them get transportation, healthy food, information, and better access to care to improve health in conditions like hypertension, diabetes, and high cholesterol.

  Recruiting at 2 sites University of Arizona · Tucson, Arizona and 1 other locations · NCT07799961

• Adapting and testing PEN-Plus in Zambian primary care

  Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.

  Recruiting Centre for Infectious Disease Research in Zambia · Lusaka, Lusaka Province · NCT07753681

• Home-based cardiovascular health screening for people turning 50, 55, 60, 65, 70 or 75 in Uppsala

  This trial tests whether giving people a home blood pressure monitor, a dried blood spot kit, and a questionnaire can find more cardiovascular risk factors than usual care.

  Recruiting Uppsala University · Uppsala · NCT07614659

• Goal-commitment coaching to boost proactive health actions in adults with hypertension, diabetes, or high cholesterol

  This project will try a goal-commitment behavioral program to see if it helps adults with hypertension, diabetes, or high cholesterol adopt more proactive health habits.

  Recruiting Huazhong University of Science and Technology · Wuhan, Hubei · NCT07552571

• Environmental and inflammatory links to metabolic and endocrine diseases

  This project will see if combining environmental, genetic, and protein information can help predict early risk of diabetes, hypertension, and other metabolic or endocrine problems in community adults.

  Recruiting Chongqing Medical University · Chongqing · NCT07512609

• Pharmacist-led care pathway for type 2 diabetes in Alberta community pharmacies

  This project will test whether a pharmacist-led care pathway in community pharmacies can help adults with type 2 diabetes and HbA1c above 7.0% lower their blood sugar and improve care compared with usual physician or nurse practitioner care.

  Recruiting University of Alberta · Edmonton, Alberta · NCT07339852

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.